Turkish Adaptation of the CSQ-VR

Abant Izzet Baysal University

Status: Not yet enrolling

Conditions: Healthy Volunteers

Study type: Observational

Funder types: Other

Identifiers

NCT07247773

AIBU-FTR-BENLI-008

Details and patient eligibility

About

The Cybersickness in Virtual Reality Questionnaire (CSQ-VR) is a tool designed to measure the presence and intensity of cybersickness symptoms experienced in VR. The CSQ-VR is an adapted and improved version of the Cybersickness section of the Virtual Reality Neuroscience Questionnaire (VRNQ). The aim of this study is to examine the validity and reliability of the Turkish version of the CSQ-VR.

Full description

Alongside the many innovations brought by virtual reality, some users may experience the phenomenon of cybersickness. Symptoms of cybersickness include nausea, disorientation, and oculomotor disturbances. Although cybersickness shares similarities with simulator sickness, it differs in terms of the frequency and severity of symptoms. In particular, users who experience cybersickness report increased overall discomfort due to nausea and disorientation. Cybersickness is also distinct from motion sickness, as cybersickness is triggered by visual stimulation, whereas motion sickness is induced by actual physical movement.

Although there is no comprehensive theoretical framework for cybersickness, the most common and dominant explanation is the sensory conflict theory. This framework suggests that the symptomatology of cybersickness arises from a sensory conflict between the vestibular (inner ear) and visual systems. Simply put, the perception of postural balance depends on a combination of visual, vestibular, and proprioceptive inputs. It is assumed that conflicting motion perception cues from these systems cause cybersickness. The technological source of this conflict is vection, an illusory sense of self-motion induced in VR. Vection is considered one of the main causes of cybersickness in VR. In particular, movements such as linear and angular accelerations are reported to provoke cybersickness in users.

Enrollment: 42 estimated patients

Sex: All

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Voluntary agreement to participate in the study
• Ability to stand and walk independently

Exclusion criteria

• Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
• Failure on the butterfly test of the Titmus stereotest

Trial design

42 participants in 1 patient group

Healthy volunteer

Description:

A group of healthy participants will rate the symptoms induced in virtual reality using questionnaire items.